1. Home
  2. APGE vs BBAI Comparison

APGE vs BBAI Comparison

Compare APGE & BBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • BBAI
  • Stock Information
  • Founded
  • APGE 2022
  • BBAI 2020
  • Country
  • APGE United States
  • BBAI United States
  • Employees
  • APGE N/A
  • BBAI N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • BBAI EDP Services
  • Sector
  • APGE Health Care
  • BBAI Technology
  • Exchange
  • APGE Nasdaq
  • BBAI Nasdaq
  • Market Cap
  • APGE 2.4B
  • BBAI 2.9B
  • IPO Year
  • APGE 2023
  • BBAI N/A
  • Fundamental
  • Price
  • APGE $66.64
  • BBAI $5.46
  • Analyst Decision
  • APGE Strong Buy
  • BBAI Strong Buy
  • Analyst Count
  • APGE 9
  • BBAI 2
  • Target Price
  • APGE $97.33
  • BBAI $7.00
  • AVG Volume (30 Days)
  • APGE 730.3K
  • BBAI 123.2M
  • Earning Date
  • APGE 11-10-2025
  • BBAI 11-10-2025
  • Dividend Yield
  • APGE N/A
  • BBAI N/A
  • EPS Growth
  • APGE N/A
  • BBAI N/A
  • EPS
  • APGE N/A
  • BBAI N/A
  • Revenue
  • APGE N/A
  • BBAI $144,199,000.00
  • Revenue This Year
  • APGE N/A
  • BBAI N/A
  • Revenue Next Year
  • APGE N/A
  • BBAI $13.83
  • P/E Ratio
  • APGE N/A
  • BBAI N/A
  • Revenue Growth
  • APGE N/A
  • BBAI N/A
  • 52 Week Low
  • APGE $26.20
  • BBAI $2.02
  • 52 Week High
  • APGE $67.66
  • BBAI $10.36
  • Technical
  • Relative Strength Index (RSI)
  • APGE 73.22
  • BBAI 40.95
  • Support Level
  • APGE $61.81
  • BBAI $5.38
  • Resistance Level
  • APGE $67.66
  • BBAI $6.49
  • Average True Range (ATR)
  • APGE 3.73
  • BBAI 0.65
  • MACD
  • APGE 0.19
  • BBAI -0.06
  • Stochastic Oscillator
  • APGE 91.78
  • BBAI 16.67

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About BBAI BigBear.ai Inc.

BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.

Share on Social Networks: